Abstract
BACKGROUND
Diabetics have a 3-fold risk for cardiovascular diseases compared with non-diabetics. This study was designed to evaluate cerebral hemodynamic changes related to type 2 diabetes mellitus (DM) with transcranial Doppler ultrasonography (TCD). TCD is a highly sensitive and specific method of quick bedside assessment of cerebrovascular circulation hemodynamics.
PATIENTS AND METHODS
In a prospective study, we compared a group of 100 patients with the diagnosis of type 2 diabetes mellitus (aged 48 to 67 years) and an age- and sex-matched control group of 100 healthy subjects without diabetes mellitus. We measured flow velocities (Vm) and the Gosling pulsatility index (PI) of the middle cerebral artery (MCA).
RESULTS
The rate of TCD abnormalities was significantly higher in diabetic patients than in healthy control subjects (55% vs. 11%, P<0.05). The PI was significantly higher in diabetic patients than in healthy controls (P<0.001). Atherosclerotic changes were found in 34.0% and 71.4% of patients suffering from diabetes for <5 and ≥5 years, respectively.
CONCLUSION
This study suggests that TCD is a useful marker for the detection of diabetic cerebrovascular changes. The duration and type of diabetes were found to have an impact on the development of pathologic cerebrovascular changes.
Diabetes mellitus is a major independent risk factor for cerebrovascular disease (CVD), especially for ischemic stroke. After adjustment for age, blood pressure, cigarette smoking and cholesterol level, diabetics have a 3-fold risk for cardiovascular diseases compared with non-diabetics. This also applies to cardiovascular death, coronary heart disease and stroke.1–5 Transcranial Doppler sonography (TCD) is a modern and sophisticated diagnostic procedure that enables visualization of hemodynamic changes in the basal cerebral arteries in real time and the recording of changes in cerebral perfusion in various physiological and pathophysiological states.6–11 TCD is a highly sensitive and specific method for quick bedside assessment of cerebrovascular circulation hemodynamics.12 Hemodynamic disturbance worsens brain artery autoregulation and disturbs development of collateral circulation and compensatory flow. The aim of the study was to evaluate the Doppler characteristics of patients with diabetes mellitus compared with healthy control subjects.
Patients and Methods
This prospective study was carried out at the General Hospital Slavonski Brod between January to December 2003. The study included a group of 100 patients aged 48–67 years, with the diagnosis of diabetes mellitus, and an age- and sex-matched control group of 100 healthy subjects. Diabetic patients were divided into two subgroups according to the duration of diabetes (<5 and ≥5 years). Study patients had no risk factors for cerebrovascular disease other than type 2 DM. Healthy controls had no risk factors for cerebrovascular disease, including smoking, hypertension, dyslipidemia, obesity and diabetes. Study patients were treated with oral antidiabetic drugs. Study patients had no signs of cerebrovascular disease and were without anatomic variation of the circle of Willis at enrollment. TCD was performed by leaning a pulsating ultrasound 2 MHz (Transscan 30 EME, Uberlingen, Germany) probe against the temporal windows, and screening the flow in the blood vessels of the circle of Willis according to standard criteria. A hemodynamic chart was designed, the frequency of the mean blood flow velocity spectra (MBFV; systolic, diastolic and mean) was analyzed, and sound phenomena and flow disturbances in terms of turbulence, stenosis or occlusion were recorded. We measured flow velocities (Vm) and the Gosling pulsatility index (PI) of the middle cerebral artery (MCA) in patients and healthy controls.13,14 The normal value of the PI is from 0.6 to 1.1; arterial stenosis is less than 0.6 and a value above 1.1 indicates attenuation of flow. Criteria for stenosis of the MCA are a significant focal mean flow velocity increase (MFV >80 cm/s), and/or a peak systolic velocity increase (PSV <140 cm/s), and/or a interhemispheric MBFV difference >30 cm/s in adult. Additional findings may include turbulence or disturbed flow distal to the stenosis, increased unilateral anterior cerebral artery (ACA) MFV indicating compensatory flow diversion. This finding may also indicate A1 ACA or an internal carotid artery (ICA) bifurcation stenosis with a side-to-side ACA MFV ratio >1.2, a low-frequency noise produced by non-harmonic covibrations of the vessel wall and musical murmurs due to harmonic covibrations producing pure tones.6 On statistical analysis, the proportion test was used.
Results
In the study population of 100 patients (46 men, 54 women) with diabetes mellitus type 2 (aged 48 to 67 years, mean 58±2 years) and an age- and sex-matched control group of 100 healthy subjects without diabetes mellitus, TCD investigation showed two specific types of hemodynamic changes in diabetic patients. One was attenuation of the cerebral spectra and deceleration of MBFV in all or most of the arteries of the circle of Willis, which indicates cerebral microangiopathy. The other change was acceleration of MBFV, turbulence and a pathologic sound phenomena in some arteries of the circle of Willis, which indicates atherosclerotic plaques and stenosis of arteries of the circle of Willis or macroangiopathy. We found a statistically significantly higher rate of abnormalities in diabetic patients than in the control group of healthy subjects (55% vs. 11%; P<0.05), (Table 1). The PI was significantly higher in diabetic patients than in healthy controls (P<0.001).
Table 1.
Healthy controls (n=100) | Diabetic patients (n=100) | |
---|---|---|
Normal TCD (%) | 89 | 45 |
Abnormal TCD (%) | 11 | 55 |
P<0.001 healthy controls vs. diabetic patients
The type of diabetes plays a prominent role in the development of cerebrovascular disease in diabetic patients as well as in the character of these lesions. Comparison of the duration of diabetes and changes in cerebral hemodynamics in diabetic patients produced interesting results as well. In the group of 44 diabetics with diabetes duration of up to 5 years, signs were observed in 34% of patients. In the group of 56 diabetics with diabetes duration of ≥5 years, angiopathy was present in 71.4% of patients. Pathologic atherosclerotic lesions of cerebral arteries were found in 34% of diabetic patients with diabetes duration of <5 years and in 71.4% of those with diabetes duration of ≥5 years. These results yielded a statistically significantly higher rate of pathologic cerebral artery changes in patients with diabetes duration of ≥5 years (P<0.05). In the control group, angiopathy was detected in 11% of the subjects (Table 2).
Table 2.
Angiopathy (%) | |
---|---|
DM <5 years (n=44) | 34 |
DM ≥5 years (n=56) | 71.4 |
Healthy controls (n=100) | 11 |
P<0.05 DM <5 years vs. DM ≥5 years
Discussion
Diabetes mellitus is one of the most important risk factors for CVD.1,15 In the Framingham study, the incidence of stroke in diabetic patients aged 45–74 years was 2.5- to 3.5-fold that found in nondiabetics. 15 In diabetics, the risk of stroke is twofold that in nondiabetics16 and diabetic patients are at a higher risk of stroke recurrence.17 Diabetes mellitus is a metabolic disease involving all arteries and is frequently associated with stroke development along with peripheral vasculopathy and coronary disease. 15–18 The mechanism of atherosclerotic changes in diabetic patients has not been fully elucidated, but the following causes have been proposed: a decrease in HDL cholesterol, proliferation of smooth muscle cells, changes in the metabolism of glucosamino-glycans, increased level of thromboxane, decreased prostacyclines, and blood coagulation impairment. Insulin stimulates smooth muscle cell proliferation in the arterial wall and the activity of LDL receptors. 19 In our study, we found a significant relationship between the duration of diabetes and cerebral hemodynamic disturbances. In the group of diabetic patients with a disease duration of <5 years atherosclerotic changes were more common than in patients with a duration ≥5 years (71.4% vs. 34.0%).
The results of our study showed that the prevalence of cerebral hemodynamic abnormalities was statistically significantly higher in diabetic patients as compared with healthy control subjects without DM. The duration of diabetes play an important role in the development of pathologic changes in cerebral vessels. On the other hand, duration of diabetes was found to predict the development of atherosclerotic processes in brain vessels. In all our diabetic patients, the signs of cerebral angiopathy, affecting cerebral perfusion and probably gradually leading to collapse of cerebral autoregulation, were seen in these patients. Compared to Elmore and al.20 we studied a younger population without risk factors other than type 2 DM for development of cerebrovascular disease. The duration of type 2 DM reflected significantly on hemodynamic disturbance and confirms the importance of DM as a main risk factor for development of cerebrovascular disease.
References
- 1.O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (The Cardiovascular Health Study Collaborative Research Group) N Engl J Med. 1999;340(1):14–22. doi: 10.1056/NEJM199901073400103. [DOI] [PubMed] [Google Scholar]
- 2.Mudrikova T, Szaboova E, Tkac I. Carotid intima-media thickness in relation to macro-vascular disease in patients with type 2 diabetes mellitus. Wiener Klinische Wochenschrift. 2000;112(20):887–891. [PubMed] [Google Scholar]
- 3.Hunt KJ, Williams K, Rivera D, O’Leary DH, Haffner SM, Stern MP, Villalpando CG. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arteriosclerosis Thrombosis & Vascular Biology. 2003;23(10):1845–1850. doi: 10.1161/01.ATV.0000093471.58663.ED. [DOI] [PubMed] [Google Scholar]
- 4.Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000;43(2):156–164. doi: 10.1007/s001250050024. [DOI] [PubMed] [Google Scholar]
- 5.Kokic S, Radman M, Capkun V, Kokic-Dovzak D, Tesanovic S. Comparative assessment of the treatment of type 2 diabetes mellitus. Annals of Saudi Medicine. 2002;22(3–4):163–166. doi: 10.5144/0256-4947.2002.163. [DOI] [PubMed] [Google Scholar]
- 6.Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasoud recording of flow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769–74. doi: 10.3171/jns.1982.57.6.0769. [DOI] [PubMed] [Google Scholar]
- 7.McCartney JP, Kathleen M, Lukes T, Gomez CR. Handbook of Transcranial Doppler. New York: Springer-Verlag; 1997. pp. 1–85. [Google Scholar]
- 8.Krejza J, Mariak Z, Walecki J, Szydlik P, Lewko J, Ustymowicz A. Transcranial color Doppler sonography of basal cerebral arteries in 182 healthy subjects: age and sex variability and normal reference values for blood flow parameters. Am J Roentgenol. 1999;172:213–18. doi: 10.2214/ajr.172.1.9888770. [DOI] [PubMed] [Google Scholar]
- 9.Alexandrov AV, Demarin V. Insonation techniques and diagnostic criteria for transcranial Doppler sonography. Acta Clin Croat. 1999;38:97–108. [Google Scholar]
- 10.Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 1995;38:1061-S. doi: 10.1007/BF00402176. [DOI] [PubMed] [Google Scholar]
- 11.Holt R. Targeting cardiovascular risk factors in patients with type 2 diabetes. Diabetes, Obesity & Metabolism. 2003;5(4):269–73. [Google Scholar]
- 12.Wojczal J, Szerej AS, Belniak E, Blaszkowska A, Stelmasiak Z. The importance of transcranial Doppler (TCD) in the assessment of cerebrovascular hemodynamics of the acute phase of ischemic stroke. Neurol Neurochir Pol. 2003;37(1):185–93. [PubMed] [Google Scholar]
- 13.Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an indeks of cerebral microangiopathy in diabetes. Stroke. 2000;31(5):1111–5. doi: 10.1161/01.str.31.5.1111. [DOI] [PubMed] [Google Scholar]
- 14.Diehl RR, Samii C, Diehl A. Dynamics and embolic activity of symptomatic intra-cranial cerebral artery stenoses. Acta Neurol Scand. 2002;106(3):173–81. doi: 10.1034/j.1600-0404.2002.01359.x. [DOI] [PubMed] [Google Scholar]
- 15.Sprafka JM, Virnig BA, Shahar E, McGovern PG. Trends in diabetes prevalence among stroke patients and the effect of diabetes on stroke survival: the Minnesota Heart Survey. Diabet Med. 1994;11:678–84. doi: 10.1111/j.1464-5491.1994.tb00332.x. [DOI] [PubMed] [Google Scholar]
- 16.Bonora E, Kiechl S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J. Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000;43(2):156–164. doi: 10.1007/s001250050024. [DOI] [PubMed] [Google Scholar]
- 17.Haffner SM, D’Agostino R, Saad MF, O’Leary DH, Savage PJ, Rewers M, Selby J, Bergman RN, Mykkanen L. Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (the insulin resistance atherosclerosis study) American Journal of Cardiology. 2000;85(12):1395–1400. doi: 10.1016/s0002-9149(00)00784-0. [DOI] [PubMed] [Google Scholar]
- 18.Spijkerman AMW, Dekker JM, Nijpels G, Jager A, Kostense PJ, van Hinsbergh VWM, Bouter LM, Heine RJ, Stehouwer CDA. Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study. European Journal of Clinical Investigation. 2002;32(12):924–930. doi: 10.1046/j.1365-2362.2002.01090.x. [DOI] [PubMed] [Google Scholar]
- 19.O’Neal DN, Dragicevic G, Rowley KG, Ansari MZ, Balazs N, Jenkins A, Best JD. A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb. Diabetes Care. 2003;26(1):199–205. doi: 10.2337/diacare.26.1.199. [DOI] [PubMed] [Google Scholar]
- 20.Elmore EM, Mosequera A, Weinberger J. The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes. J Neuroimaging. 2003;13(3):224–7. [PubMed] [Google Scholar]